Who owns Cue Biopharma Inc?
- Ticker: CUE
- CUSIP Number: 22978p106
Tip: Access positions for across all investors
Analyze quarterly positions in Cue Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cue Biopharma stock
Who bought or sold Cue Biopharma Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Bleichroeder | 6.8M | $2.1M | 0% | Dec 2025 |
|
| Catalytic Wealth RIA | 4.6M | $1.4M | 35% | Dec 2025 |
|
| Vanguard Group | 3.0M | $919k | -1% | Dec 2025 |
|
| Lion Point Capital | 2.2M | $673k | 100% | Dec 2025 |
|
| Geode Capital Management | 803k | $245k | 0% | Dec 2025 |
|
| Boothbay Fund Management | 704k | $215k | 15% | Dec 2025 |
|
| Robertson Stephens Wealth Management | 479k | $146k | 0% | Dec 2025 |
|
| BlackRock | 449k | $137k | 0% | Dec 2025 |
|
| Texas Capital Bank Wealth Management Services | 441k | $135k | 1231% | Dec 2025 |
|
| Angeles Wealth Management | 310k | $95k | 158% | Dec 2025 |
|
| Advisory Research | 257k | $79k | 0% | Dec 2025 |
|
| Stifel Financial | 247k | $75k | 25% | Dec 2025 |
|
| Renaissance Technologies | 238k | $73k | 5% | Dec 2025 |
|
| State Street Corporation | 179k | $55k | -5% | Dec 2025 |
|
| Susquehanna International | 169k | $52k | 1% | Dec 2025 |
|
| Northern Trust | 101k | $31k | 0% | Dec 2025 |
|
| Chicago Partners Investment | 86k | $33k | 0% | Dec 2025 |
|
| Northwestern Mutual Wealth Management Company | 80k | $24k | 0% | Dec 2025 |
|
| Jane Street | 70k | $21k | 100% | Dec 2025 |
|
| UBS Group | 47k | $14k | -76% | Dec 2025 |
|
| LPL Financial | 46k | $14k | 0% | Dec 2025 |
|
| Sigma Planning | 41k | $13k | -23% | Dec 2025 |
|
| Hrt Financial | 21k | $6.0k | 100% | Dec 2025 |
|
| Cambridge Investment Research Advisors | 20k | $6.0k | 0% | Dec 2025 |
|
| Goss Wealth Management | 20k | $6.1k | 0% | Dec 2025 |
|
| Prevail Innovative Wealth Advisors | 19k | $5.8k | 0% | Dec 2025 |
|
| Goldman Sachs Group | 14k | $4.4k | 0% | Dec 2025 |
|
| HighTower Advisors | 11k | $3.3k | 100% | Dec 2025 |
|
| SeaCrest Wealth Management | 10k | $3.9k | 0% | Dec 2025 |
|
| Barclays | 6.0k | $1.8k | 0% | Dec 2025 |
|
| Gleason Group | 6.0k | $1.8k | 0% | Dec 2025 |
|
| New Millennium Group | 5.8k | $1.8k | 100% | Dec 2025 |
|
| Newbridge Financial Services Group | 3.0k | $915.900000 | 0% | Dec 2025 |
|
| Wells Fargo & Company | 2.6k | $782.996500 | -87% | Dec 2025 |
|
| Simplex Trading | 2.6k | $779.885000 | -47% | Dec 2025 |
|
| Golden State Wealth Management | 2.0k | $611.000000 | 0% | Dec 2025 |
|
| Tidemark | 1.5k | $457.950000 | 0% | Dec 2025 |
|
| UMA Financial Services | 1.0k | $308.037200 | 0% | Dec 2025 |
|
| Jpmorgan Chase & Co | 904.00 | $649.976000 | 100% | Sep 2025 |
|
| Advisor Group Holdings | 680.00 | $208.556000 | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 415.00 | $126.990000 | -40% | Dec 2025 |
|
| Jones Financial Companies, L.L | 400.00 | $122.000000 | 100% | Dec 2025 |
|
| MAI Wealth Advisors | 350.00 | $106.995000 | 0% | Dec 2025 |
|
| Armstrong Advisory Group | 120.00 | $36.996000 | 0% | Dec 2025 |
|
| IFP Advisors | 100.00 | $31.000000 | 0% | Dec 2025 |
|
Who sold out of Cue Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Squarepoint Ops | Sep 2025 | 86k | $62k |
| Two Sigma Securities | Sep 2025 | 40k | $28k |
| Navalign | Sep 2025 | 25k | $18k |
| Virtu Financial | Sep 2025 | 15k | $11k |
| XTX Topco | Sep 2025 | 15k | $11k |
| Tower Research Capital | Sep 2025 | 10k | $7.3k |
| Mather Group | Sep 2025 | 1.0k | $719.000000 |
| Sunbelt Securities | Sep 2025 | 237.00 | $170.000100 |
| Advisory Services Network | Sep 2025 | 200.00 | $144.000000 |